Strengthening surveillance for vaccine-preventable diseases through measles and rubella elimination

Author： Spika John S   Lipskaya Galina   Emiroglu Nedret  

Publisher： Future Medicine

ISSN： 1746-0794

Source： Future Virology, Vol.2, Iss.5, 2007-09, pp. : 445-450

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A post-marketing surveillance study has revealed no new evidence to suggest that the new measles mumps and rubella virus (MMR) vaccine [Priorix]

By  

Reactions Weekly, Vol. 1, Iss. 1150, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Measles, Mumps, Rubella Vaccine (Priorix™; GSK-MMR): A Review of its Use in the Prevention of Measles, Mumps and Rubella

By Wellington K.   Goa K.L.  

Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. : 2107-2126

Adis International

Access to resources Recommend Favorite

Measles and rubella virus vaccine: Transverse myelitis in a child: case report

By  

Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Measles and rubella virus vaccine: Optic neuritis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1019, 2004-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Measles rubella vaccine conjugate: Idiopathic thrombocytopenic purpura in an infant: case report

By  

Reactions Weekly, Vol. 1, Iss. 1178, 2007-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite